Cargando…

Editorial: Non-genetic adaptive drug resistance in cancer

Detalles Bibliográficos
Autores principales:	Cerezo, Michaël, Sun, Xiaoxiao, Shen, Shensi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716313/ https://www.ncbi.nlm.nih.gov/pubmed/36467421 http://dx.doi.org/10.3389/fcell.2022.998339

Ejemplares similares

Editorial: Adopting drug repurposing to overcome drug resistance in cancer
por: Shankar, Eswar, et al.
Publicado: (2023)

Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy
por: Li, Lianbo
Publicado: (2022)

Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
por: Wei, Ling, et al.
Publicado: (2021)

Editorial: Non-Coding RNAs in Gastrointestinal and Gynecological Cancers: New Insights Into the Mechanisms of Cancer Therapeutic Resistance
por: Dong, Peixin, et al.
Publicado: (2022)

Editorial: Non-coding RNAs in gastrointestinal and gynecological cancers: New insights into the mechanisms of cancer therapeutic resistance, volume II
por: Dong, Peixin, et al.
Publicado: (2023)

Editorial: Molecular drivers of prostate cancer pathogenesis and therapy resistance
por: Patel, Girijesh Kumar, et al.
Publicado: (2023)

Editorial: Metabolic Adaptation of Muscle Tissue in Diseases Associated With Cachexia
por: Cirillo, Federica, et al.
Publicado: (2022)

Editorial: Genetic Mutations Associated With Ocular Diseases
por: Yu, Minzhong, et al.
Publicado: (2021)

Editorial: With the Eyes on Non-coding RNAs
por: Ashery-Padan, Ruth, et al.
Publicado: (2021)

Editorial: Genetic features contributing to eye development and disease
por: Xu, Wenchang, et al.
Publicado: (2022)

Role of Tet2 in Regulating Adaptive and Innate Immunity
por: Li, Jiaqi, et al.
Publicado: (2021)

Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer
por: Wei, Ling, et al.
Publicado: (2023)

Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance
por: Ruocco, Maria Rosaria, et al.
Publicado: (2022)

Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations
por: Pendleton, Katherine E., et al.
Publicado: (2023)

Editorial: Non-coding RNAs in Reproductive Biology
por: Meng, Li, et al.
Publicado: (2021)

Editorial: Multidisciplinary Approaches in Exploring Cancer Heterogeneity, TME and Therapy Resistance: Perspectives for Systems Medicine
por: Pützer, Brigitte M., et al.
Publicado: (2022)

Editorial: Genetic, Environmental and Synergistic Gene-Environment Contributions to Craniofacial Defects
por: Anderson, Peter J., et al.
Publicado: (2022)

Editorial: Deciphering the etiology of rare genetic disorders associated with protein phosphatases
por: Janssens, Veerle, et al.
Publicado: (2023)

Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
por: Burke, Matthew R., et al.
Publicado: (2022)

Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer
por: Mao, Chengyi, et al.
Publicado: (2021)

Editorial: Emerging Proteins and Polypeptides Expressed by “Non-Coding RNAs”
por: Liu, Wanting, et al.
Publicado: (2022)

Editorial: Non-apoptotic cell death mechanisms and their therapeutic significance
por: Lopus, Manu, et al.
Publicado: (2022)

Editorial: Non-cell Cycle Functions of Cell Cycle Regulators
por: Liu, Song-Tao, et al.
Publicado: (2019)

Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer
por: Yang, Ruixue, et al.
Publicado: (2022)

Editorial: Modeling neuromuscular diseases to determine molecular drivers of pathology and for drug discovery
por: Smith, Alec S. T., et al.
Publicado: (2022)

Editorial: Metabolism and Cell Adhesion in Cancer
por: Hartmann, Tanja Nicole
Publicado: (2022)

Editorial: Molecular Mechanisms of Autophagy in Cancer
por: Humbert, Magali, et al.
Publicado: (2022)

Editorial: The Use of Organoids in Cancer Biology
por: Xue, Xiang, et al.
Publicado: (2022)

Editorial: Kinase inhibitors in cancer therapy
por: Yadav, Dharmendra Kumar
Publicado: (2022)

Editorial: Epigenetic Reprogramming and Cancer Development
por: Brown, Geoffrey, et al.
Publicado: (2020)

Editorial: The development of lethal prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2023)

Editorial: Targeted therapies for aggressive cancers
por: Lee, Sean B., et al.
Publicado: (2023)

Editorial: Tumor microenvironment and cancer therapy
por: Xie, Yi, et al.
Publicado: (2023)

Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor
por: Li, Jiehan, et al.
Publicado: (2022)

Editorial: Immune modulation in tumor microenvironment: New perspectives for cancer immunotherapy
por: Deng, Zimu, et al.
Publicado: (2023)

Editorial: Advances in genomic and genetic tools, and their applications for understanding embryonic development and human diseases
por: Abu-Elmagd, Muhammad, et al.
Publicado: (2022)

Editorial: Role of non-coding RNAs in development and metastasis of solid tumours
por: Roy, Bappaditya, et al.
Publicado: (2023)

The Role and Therapeutic Value of Syndecan-1 in Cancer Metastasis and Drug Resistance
por: Guo, Sen, et al.
Publicado: (2022)

Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment
por: Luan, Siyuan, et al.
Publicado: (2021)

Editorial: Mechanistic studies of genome integrity, environmental health, and cancer etiology
por: Yan, Shan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q6jq06qv5q96lo6f43ukh0dn3b